Cargando…
Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases
BACKGROUND: Data from the Surveillance, Epidemiology, and End Results program and the European Concerted Action on survival and Care of Cancer Patients (EUROCARE) project indicate that about 6% of women newly diagnosed with breast cancer have stage IV disease, representing about 12 600 new cases per...
Autores principales: | Le Scodan, Romuald, Ali, David, Stevens, Denise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993682/ https://www.ncbi.nlm.nih.gov/pubmed/21083907 http://dx.doi.org/10.1186/1471-2407-10-630 |
Ejemplares similares
-
The optimal sequence of radiotherapy and chemotherapy in adjuvant treatment of breast cancer
por: Abbas, Hamza, et al.
Publicado: (2011) -
Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice
por: Fogarty, Gerald B., et al.
Publicado: (2016) -
Exclusive breastfeeding: measurement and indicators
por: Greiner, Ted
Publicado: (2014) -
Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care
por: Epstein, Richard J
Publicado: (2007) -
Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy
por: Zhang, Chi, et al.
Publicado: (2015)